|
|
雾化吸入疗法急诊临床应用专家共识(2018) |
中国医师协会急诊医师分会,中国人民解放军急救医学专业委员会,北京急诊医学学会,中国急诊专业联合体 |
|
[1]Elliott D, Dunne P. Guide to aerosol delivery devices for physicians, nurses, pharmacists, and other health care professionals[J]. Am Assoc Resp Care, 2011: 1-64.
[2]Ibrahim M, Verma R, Garcia-Contreras L, et al. Inhalation drug delivery devices: technology update[J]. Med Devices (Auckl), 2015, 8:131-139.
[3]中华医学会呼吸病学分会《雾化吸入疗法在呼吸疾病中的应用专家共识》制定专家组. 雾化吸入疗法在呼吸疾病中的应用专家共识[J]. 中华医学杂志, 2016, 96(34): 2696-2708.
[4]于启林,朱士俊,梁爱萍,等. 82598例急诊患者疾病分类调查[J]. 中华医院管理杂志, 2001, 17(10): 599-601.
[5]郝璐,尹文,黄杨,等. 55650例急诊病例疾病谱分析及护理对策[J]. 护理学杂志, 2008, 23(5): 32-34.
[6]Trnjar K, PintaricS, Mornar JelavicM, et al. Correlation Between Occurrence and Deterioration of Respiratory Diseases and Air Pollution Within the Legally Permissible Limits[J]. Acta Clin Croat, 2017, 56(2): 210-217.
[7]Zhang H, Niu Y, Yao Y, et al. The Impact of Ambient Air Pollution on Daily Hospital Visits for Various Respiratory Diseases and the Relevant Medical Expenditures in Shanghai, China[J]. Int J Environ Res Public Health, 2018, 15(3). pii: E425.
[8]Zhu Z, Zheng J, Wu Z, et al. Clinical practice of nebulized therapy in China: a national questionnaire survey[J]. J Aerosol Med Pulm Drug Deliv, 2014, 27(5): 386-391.
[9]Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs[J]. Expert Opin Drug Deliv, 2015, 12(6): 889-900.
[10]Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology[J]. Chest, 2005, 127(1): 335-371.
[11]中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(9): 675-697.[12]申昆玲,邓力,李云珠,等. 糖皮质激素雾化吸入疗法在儿科应用的专家共识(2018年修订版)[J]. 临床儿科杂志, 2018, 36(2): 95-107.
[13]Dahlstrm K, Thorsson L, Larsson P, et al. Systemic availability and lung deposition of budesonide via three different nebulizers in adults[J]. Ann Allergy Asthma Immunol, 2003, 90(2): 226-232.
[14]Chen AH, Zeng GQ, Chen RC, et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study[J]. Respirology, 2013, 18(Suppl 3): 47-52.
[15]支修益,卫生部临床路径专家委员会胸外科专家组. 胸外科围手术期气道管理专家共识(2012年版)[J]. 中国胸心血管外科临床杂志, 2013, 20(3): 251-255.
[16]多学科围手术期气道管理专家共识(2016年版)专家组. 多学科围手术期气道管理专家共识(2016年版)[J]. 中华胸部外科电子杂志, 2016, 3(3): 129-133.
[17]Sun X, He Z, Zhang J, et al. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD[J]. Pulm Pharmacol Ther, 2015, 31(1): 111-116.
[18]Brattsand R, Miler-Larsson. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity[J]. Clin Ther, 2003, 25 (Suppl C): C28-C41.
[19]Zhou J, Liu DF, Liu C, et al. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism[J]. Allergy, 2008, 63(9): 1177-1185.
[20]Mendes ES, Rebolledo, Campos M, et al. Immediate antiinflammatory effects of inhaled budesonide in patients with asthma[J]. Ann Am Thorac Soc, 2014, 11(5): 706-711.
[21]Tsai YG, Lee MY, Yang KD, et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma[J]. J Pediatr, 2001, 139(3): 433-437.
[22]成人慢性气道疾病雾化吸入治疗专家组. 成人慢性气道疾病雾化吸入治疗专家共识[J]. 中国呼吸与危重监护杂志, 2012, 11(2): 105-110.
[23]中华医学会呼吸病学分会哮喘学组,中国哮喘联盟. 支气管哮喘急性发作评估及处理中国专家共识[J]. 中华内科杂志, 2018, 57(1): 4-14.
[24]刘海英,邱林. 急性喉梗阻的急救护理[J]. 中国医药指南, 2016, 14(32): 271-272.
[25]中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2015)[J]. 中华结核和呼吸杂志, 2016, 39(5): 323-354.
[26]赖克方,刘宝娟. 激素敏感性咳嗽的临床特征与治疗[J]. 中国临床医生, 2014, 42(7): 8-10.
[27]中国医师协会急诊医师分会. 急诊成人社区获得性肺炎诊治专家共识(一)[J]. 中国急救医学, 2011, 31(10): 865-871.
[28]Rello J, Solé-Lleonart C, Rouby JJ, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases[J]. Clin Microbiol Infect, 2017, 23(9): 629-639.
[29]中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2): 97-107.
[30]慢性气道炎症性疾病气道黏液高分泌管理中国专家共识编写组. 慢性气道炎症性疾病气道黏液高分泌管理中国专家共识[J]. 中华结核和呼吸杂志, 2015, 38(10): 723-729.
[31]Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25(9): 603-605.
[32]Elamin E, Miller A. Impact of nebulized unfractionated heparin and N-acetylcysteine in management of smoke inhalation injury[J]. Crit Care, 2009, 13(Suppl 1): 438.
[33]Hashemian SM, Mortaz E, Jamaati H, et al. Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells[J]. J Crit Care, 2018, 44: 161-167.
[34]Mohamed H S, Meguid MM. Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury/acute respiratory distress syndrome: Randomized controlled study[J]. Saudi J Anaesth, 2017, 11(1): 9-14.
[35]Davidson AC, Banham S, Eliott M, et al. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults[J]. Thorax, 2016, 71(Suppl 2): ii1-35.
[36]Khemani RG, Randolph A, Markovitz B. Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults[J]. Cochrane Database Syst Rev, 2009, 8(3): CD001000.
[37]Franois B, Bellisant E, Gissot V, et al. 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial[J]. Lancet, 2007, 369(9567): 1083-1089.
[38]Kashefi P, Abbasi A, Abbasi M, et al. Comparison of the efficacy of nebulized budesonide and intravenous dexamethasone administration before extubation in prevention of post-extubation complications among patients admitted in intensive care unit[J]. Adv Biomed Res, 2015, 4: 11.
[39]Arulparithi CS, Babu TA, Ravichandran C, et al. Efficacy of nebulised budesonide versus oral prednisolone in acute severe asthma[J]. Indian J Pediatr, 2015, 82(4): 328-332.
[40]中华医学会呼吸病学分会哮喘学组,中国哮喘联盟. 重症哮喘诊断与处理中国专家共识[J]. 中华结核和呼吸杂志, 2017, 40(11): 813-829.
[41]Harris L. Comparison of cardiorespiratory effects of terbutaline and salbutamol aerosols in patients with reversible airways obstruction[J]. Thorax, 1973, 28(5): 592-595.
[42]Cazzola M, Page CP, Calzetta L, et al. Pharmacology and therapeutics of bronchodilators[J]. Pharmacol Rev, 2012, 64(3): 450-504.
[43]中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志, 2016, 54(3): 167-181. |
[1] |
郭蔚虹,孙琼其,陈瑞娟. 中性粒细胞CD64及降钙素原预测创伤性脑损伤患者预后的价值[J]. 中国急救医学, 2019, 39(9): 850-854. |
[2] |
郝晓萍,邬碧波,张黎明,俞华,唐琦. 尿肝型脂肪酸结合蛋白血清胱抑素C对急性失代偿性心力衰竭患者发生急性肾损伤的预测价值[J]. 中国急救医学, 2019, 39(9): 859-863. |
[3] |
刘传道,吕双喜,昝云强,朱红军,杨卫新. 颈髓损伤后体位性低血压患者尿中香草扁桃酸变化分析[J]. 中国急救医学, 2019, 39(9): 832-834. |
[4] |
赵晓东,于学忠. 改变中国急诊不均衡现状共融 共享 共赢共发展”的中国急诊专科医联体正在走来[J]. 中国急救医学, 2019, 39(9): 815-818. |
[5] |
中国医师协会急诊医师分会,中国人民解放军急救医学专业委员会,北京急诊医学学会,中国医师协会急诊医师分会急诊外科专业委员会. 中国犬咬伤治疗急诊专家共识(2019)[J]. 中国急救医学, 2019, 39(9): 819-824. |
[6] |
张乐,唐理斌,夏加伟,李云珍,韩留鑫,吕正煊. 经鼻高流量湿化氧疗在艾滋病并急性低氧性呼吸衰竭中的应用研究[J]. 中国急救医学, 2019, 39(9): 835-839. |
[7] |
乔鲁军,彭锦,胡国鑫,刘健,杨光虎,罗欢. microRNA-141与HMGB1通路在不同程度心肾综合征中的表达及临床意义[J]. 中国急救医学, 2019, 39(9): 840-844. |
[8] |
武巧云,丁维强,王云辉,刘丽霞,胡振杰. 超声引导的经皮扩张气管切开术对其并发症的影响[J]. 中国急救医学, 2019, 39(9): 855-858. |
[9] |
齐振昌,李彤,胡晓旻,稂与恒,段大为,吴鹏,马群兴,宁萌. 重症呼吸衰竭患者体外膜肺氧合支持下的院间转运[J]. 中国急救医学, 2019, 39(9): 869-872. |
[10] |
杨军,靳微,何新华,郭树彬,逯勇,杨昆,安静. 基层医护人员抢救技术培训结果的分析报告[J]. 中国急救医学, 2019, 39(9): 873-878. |
[11] |
刘国跃,王勇,陈淼. 胍丁胺对大鼠高氧性急性肺损伤的影响[J]. 中国急救医学, 2019, 39(9): 882-886. |
[12] |
程云,何英,段海真,华维,张天喜,陆元兰,喻安永. 主髂动脉闭塞症引起腹胀1例分析[J]. 中国急救医学, 2019, 39(9): 913-914. |
[13] |
刘伯轩,陈成,龚九妹,李东璟,肖淳文,徐旭东. 颅脑损伤术后脑梗死患者D-二聚体和超敏C反应蛋白的表达及预后相关性研究[J]. 中国急救医学, 2019, 39(9): 878-881. |
[14] |
马东阳,李艳丽,张志强,边庆虎,李亚男,安琪,张山. 大鼠全脑缺血再灌注损伤对海马CA1区胶质细胞谷氨酸转运体1表达的影响[J]. 中国急救医学, 2019, 39(9): 887-892. |
[15] |
赵浩天,龙玲,任珊,赵鹤龄. 床旁肺超声对气胸诊断价值的研究进展[J]. 中国急救医学, 2019, 39(9): 892-897. |
|
|
|
|